Neoleukin Therapeutics

Neoleukin Therapeutics: Develops next-generation immunotherapies for cancer, inflammation and autoimmunity using de novo protein design technology. Its lead product candidate, NL-201, is a combined IL-2 and IL-15 agonist designed to improve tolerability and activity by eliminating the alpha receptor binding interface. NL-201 is currently being evaluated in a Phase 1 clinical trial in patients with relapsed or refractory cancer and the company is expecting interim data in 2022. Cash $164.2M as of June 30, 2021; sufficiently capitalized to fund operations into 2023
Healthcare/Drug Manufacturers
Based in...
US - Pacific
Clinical Stage
Pre-Clinical Stage
Disease Space
Allergy, Autoimmune, Immuno-Oncology, Infectious Disease, Oncology
Public, USA
Market Cap
1616 Eastlake Avenue E
Suit 360
Seattle, WA 98109
United States

Company Participants at Solebury Trout Hamptons CEO Roundtable 2021

  • Jonathan G. Drachman, Pres/CEO

Top 10 Holders of Neoleukin Therapeutics, Inc

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Baker Bros. Advisors LP 9.00 3,824,000 4.05 Stakes 5/12/22
Redmile Group LLC 8.16 3,465,435 3.67 13F 3/31/22
Pictet Asset Management SA 6.06 2,574,315 2.73 13F 3/31/22
BlackRock Fund Advisors 3.65 1,551,576 1.64 13F 3/31/22
The Vanguard Group, Inc. 3.01 1,278,787 1.36 Funds 4/30/22
Renaissance Technologies LLC 2.99 1,268,969 1.35 13F 3/31/22
Vanguard Group, Inc. (Subfiler) 2.92 1,240,585 1.32 13F 3/31/22
Millennium Management LLC 2.91 1,235,707 1.31 13F 3/31/22
Point72 Asset Management LP (Old) 2.88 1,225,000 1.30 13F 3/31/22
BlackRock Institutional Trust Co. NA 1.87 796,159 0.84 13F 3/31/22
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2022 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.